Ronald Hunt

Insider Reports History

Entity
Individual
Location
C/O Credit Suisse 1 St Boston Prv Eqy, 11 Madison Avenue, New York, New York
Signature
By: /s/ Michael Greco, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ronald Hunt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Iterum Therapeutics plc Director Ordinary Shares 71.4 K $100 K $1.40 Oct 1, 2023 By New Leaf Ventures III, L.P.
Iterum Therapeutics plc Director Ordinary Shares 25.6 K $35.9 K $1.40 Oct 1, 2023 By New Leaf Biopharma Opportunities II, L.P.
Harpoon Therapeutics, Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 0 $32.2 K $1.40 Mar 11, 2024 Direct
Rallybio Corp Director Option (Right to Buy) 16.5 K $29.2 K $1.77 May 15, 2024 Direct
Iterum Therapeutics plc Director Ordinary Shares 14.3 K $20.1 K $1.40 Oct 1, 2023 Direct
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 $0 $23.00 Mar 11, 2024 Direct
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 $0 $23.00 Mar 11, 2024 Indirect
Harpoon Therapeutics, Inc. Director, 10%+ Owner 8.000% Series A Redeemable Preferred Stock 0 Mar 11, 2024 Indirect
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock Warrant (Right to Buy) 0 Mar 11, 2024 Indirect
Iterum Therapeutics plc Director Restricted Share Units 0 Oct 1, 2023 Direct

Insider Reports Filed by Ronald Hunt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RLYB Rallybio Corp May 15, 2024 1 $0 4 May 17, 2024 Director
HARP Harpoon Therapeutics, Inc. Mar 8, 2024 12 $0 4 Mar 11, 2024 Director, 10%+ Owner
RLYB Rallybio Corp Jan 2, 2024 1 $51.5 K 4 Jan 4, 2024 Director
HARP Harpoon Therapeutics, Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director, 10%+ Owner
HARP Harpoon Therapeutics, Inc. Nov 27, 2023 1 $0 4 Nov 28, 2023 Director, 10%+ Owner
HARP Harpoon Therapeutics, Inc. Oct 25, 2023 4 $0 4 Oct 27, 2023 Director, 10%+ Owner
HARP Harpoon Therapeutics, Inc. Oct 1, 2023 1 $0 4 Oct 2, 2023 Director, 10%+ Owner
ITRM Iterum Therapeutics plc Oct 1, 2023 2 $0 4 Oct 2, 2023 Director
HARP Harpoon Therapeutics, Inc. Jul 1, 2023 1 $0 4 Jul 6, 2023 Director, 10%+ Owner
ITRM Iterum Therapeutics plc Jul 1, 2023 2 $0 4 Jul 3, 2023 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director, 10%+ Owner
RLYB Rallybio Corp May 17, 2023 1 $0 4 May 19, 2023 Director
HARP Harpoon Therapeutics, Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Director, 10%+ Owner
ITRM Iterum Therapeutics plc Apr 1, 2023 2 $0 4 Apr 3, 2023 Director
HARP Harpoon Therapeutics, Inc. Mar 23, 2023 2 $10 M 4 Mar 27, 2023 Director, 10%+ Owner
RLYB Rallybio Corp Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
ITRM Iterum Therapeutics plc Jan 1, 2023 2 $0 4 Jan 4, 2023 Director
ITRM Iterum Therapeutics plc Dec 23, 2022 1 $0 4 Dec 28, 2022 Director
ITRM Iterum Therapeutics plc Sep 25, 2022 1 $0 4 Sep 27, 2022 Director
ITRM Iterum Therapeutics plc Jun 25, 2022 1 $0 4 Jun 28, 2022 Director
ITRM Iterum Therapeutics plc Jun 23, 2022 2 $0 4 Jun 24, 2022 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2022 2 $45 K 4 Jun 24, 2022 Director, 10%+ Owner
ITRM Iterum Therapeutics plc Jun 15, 2022 1 $6.47 K 4 Jun 17, 2022 Director
RLYB Rallybio Corp May 24, 2022 1 $0 4 May 26, 2022 Director
ITRM Iterum Therapeutics plc Mar 25, 2022 1 $0 4 Mar 29, 2022 Director
RLYB Rallybio Corp Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
RLYB Rallybio Corp Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
RLYB Rallybio Corp Jul 28, 2021 7 $4 M 4 Aug 4, 2021 Director
ITRM Iterum Therapeutics plc Jun 23, 2021 1 $0 4 Jun 25, 2021 Director
HARP Harpoon Therapeutics, Inc. May 4, 2021 2 $0 4/A May 14, 2021 Director, 10%+ Owner
HARP Harpoon Therapeutics, Inc. Jan 11, 2021 1 $4 M 4 Aug 12, 2021 Director, 10%+ Owner